This retrospective cohort study consists of 554,585 breast cancer patients with recorded bone metastasis event and intact ER/PR information, among which 19,439 patients were confirmed with developing bone metastasis and 10,447 patients with bone-only metastasis and valid survival time (Figure 1). The gene discussed is ESR1; the disease is bone metastasis.